0001209191-17-046039.txt : 20170721 0001209191-17-046039.hdr.sgml : 20170721 20170721214939 ACCESSION NUMBER: 0001209191-17-046039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170720 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahatme Sandesh CENTRAL INDEX KEY: 0001511034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 17977452 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-20 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001511034 Mahatme Sandesh 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, CFO & CBO Common Stock 2017-07-20 4 M 0 9375 13.71 A 41736 D Common Stock 2017-07-20 4 S 0 9375 41.00 D 32361 D Common Stock 2017-07-20 4 M 0 32998 13.90 A 65359 D Common Stock 2017-07-20 4 S 0 32998 41.00 D 32361 D Common Stock 2017-07-20 4 M 0 7627 23.85 A 39988 D Common Stock 2017-07-20 4 S 0 7627 41.00 D 32361 D Common Stock 2017-07-21 4 M 0 1500 23.85 A 33861 D Non-Qualified Stock Options (right to buy) 13.71 2017-07-20 4 M 0 9375 13.71 D 2017-02-28 2026-02-28 Common Stock 9375 24591 D Non-Qualified Stock Options (right to buy) 13.90 2017-07-20 4 M 0 32998 13.90 D 2016-02-27 2025-02-27 Common Stock 32998 56866 D Non-Qualified Stock Options (right to buy) 23.85 2017-07-20 4 M 0 7627 23.85 D 2013-11-05 2022-11-05 Common Stock 7627 125605 D Incentive Stock Option (right to buy) 23.85 2017-07-21 4 M 0 1500 23.85 D 2017-02-28 2026-02-28 Common Stock 1500 14268 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 18, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction. This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 2, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction. 25% of the option became exercisable on the first anniversary of the date of hire (11/05/2012) and 1/48th of the total granted option became exercisable on each monthly anniversary thereafter, such that the option became fully exercisable on the fourth anniversary of the date of hire. /s/David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme 2017-07-21